DrugPatentWatch Database Preview
Patent: 9,132,199
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 9,132,199
| Title: | Reverse thermal gels and uses therefor |
| Abstract: | Biodegradable triblock copolymer compositions are provided which are useful in tissue engineering and drug delivery. The copolymers are reverse thermal gels in that when heated from a lower temperature to a higher temperature, they gel. These gels are useful in drug delivery when complexed with an active agent. For example the compositions can be used for intraocular injection of active agents, such as anti-angiogenic agents for treatment of a maculopathy or retinitis. |
| Inventor(s): | Friberg; Thomas R. (Pittsburgh, PA), Park; Daewon (Pittsburgh, PA), Wang; Yadong (Allison Park, PA) |
| Assignee: | University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA) |
| Application Number: | 13/581,518 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,132,199
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | LUCENTIS | ranibizumab | INJECTABLE; INJECTION | 125156 | 001 | 2006-06-30 | Start Trial | University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA) | 2030-03-05 | RX | search | |
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 002 | 2004-02-26 | Start Trial | University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA) | 2030-03-05 | RX | Orphan | search |
| Genentech | AVASTIN | bevacizumab | VIAL; INTRAVENOUS | 125085 | 001 | 2004-02-26 | Start Trial | University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA) | 2030-03-05 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,132,199
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011109732 | Feb 02, 2012 |
| World Intellectual Property Organization (WIPO) | 2011109732 | Sep 09, 2011 |
| United States of America | 2013129663 | May 23, 2013 |
| United States of America | 2014348778 | Nov 27, 2014 |
| United States of America | 2016082115 | Mar 24, 2016 |
| >Country | >Patent Number | >Publication Date |
